Protective efficacy of phosphodiesterase-1 inhibition against alpha-synuclein toxicity revealed by compound screening in LUHMES cells
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Protective efficacy of phosphodiesterase-1 inhibition against alpha-synuclein toxicity revealed by compound screening in LUHMES cells
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-09-08
DOI
10.1038/s41598-017-11664-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- α-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies
- (2017) Yvette C Wong et al. NATURE MEDICINE
- The PROMESA-protocol: progression rate of multiple system atrophy under EGCG supplementation as anti-aggregation-approach
- (2016) Johannes Levin et al. JOURNAL OF NEURAL TRANSMISSION
- Subcellular Parkinson’s Disease-Specific Alpha-Synuclein Species Show Altered Behavior in Neurodegeneration
- (2016) Rashed Abdullah et al. MOLECULAR NEUROBIOLOGY
- Induction of de novo α-synuclein fibrillization in a neuronal model for Parkinson’s disease
- (2016) Mohamed-Bilal Fares et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Efficacy of rasagiline in patients with the parkinsonian variant of multiple system atrophy: a randomised, placebo-controlled trial
- (2015) Werner Poewe et al. LANCET NEUROLOGY
- Development of Passive Immunotherapies for Synucleinopathies
- (2015) Ann-Louise Bergström et al. MOVEMENT DISORDERS
- Active immunization therapies for Parkinson's disease and multiple system atrophy
- (2015) Achim Schneeberger et al. MOVEMENT DISORDERS
- Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease
- (2015) Dong I. Lee et al. NATURE
- Silencing phosphodiesterase 7B gene by lentiviral-shRNA interference attenuates neurodegeneration and motor deficits in hemiparkinsonian mice
- (2015) Jose A. Morales-Garcia et al. NEUROBIOLOGY OF AGING
- Vinpocetine attenuates MPTP-induced motor deficit and biochemical abnormalities in Wistar rats
- (2015) S. Sharma et al. NEUROSCIENCE
- Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism
- (2015) Stanley B. Prusiner et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells
- (2014) Alisdair McNeill et al. BRAIN
- Phosphodiesterases as Therapeutic Targets for Huntington’s Disease
- (2014) Francesca Fusco et al. CURRENT PHARMACEUTICAL DESIGN
- Phosphodiesterase Inhibitors as a Target for Cognition Enhancement in Aging and Alzheimer’s Disease: A Translational Overview
- (2014) P.R.A. Heckman et al. CURRENT PHARMACEUTICAL DESIGN
- Modulation of high affinity ATP-dependent cyclic nucleotide transporters by specific and non-specific cyclic nucleotide phosphodiesterase inhibitors
- (2014) Lena Aronsen et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease
- (2014) Mike A Nalls et al. NATURE GENETICS
- Advances in targeting cyclic nucleotide phosphodiesterases
- (2014) Donald H. Maurice et al. NATURE REVIEWS DRUG DISCOVERY
- Trifluoperazine rescues human dopaminergic cells from wild-type α-synuclein-induced toxicity
- (2014) Matthias Höllerhage et al. NEUROBIOLOGY OF AGING
- Antiplatelet effect of AMP-activated protein kinase activator and its potentiation by the phosphodiesterase inhibitor dipyridamole
- (2013) Yingqiu Liu et al. BIOCHEMICAL PHARMACOLOGY
- The Function of α-Synuclein
- (2013) Jacob T. Bendor et al. NEURON
- Fibrillar α-Synuclein and Huntingtin Exon 1 Assemblies Are Toxic to the Cells
- (2012) Laura Pieri et al. BIOPHYSICAL JOURNAL
- Piracetam and vinpocetine ameliorate rotenone-induced Parkinsonism in rats
- (2012) DinaM Abo-Elmatty et al. INDIAN JOURNAL OF PHARMACOLOGY
- The many faces of α-synuclein: from structure and toxicity to therapeutic target
- (2012) Hilal A. Lashuel et al. NATURE REVIEWS NEUROSCIENCE
- The role of calcium and mitochondrial oxidant stress in the loss of substantia nigra pars compacta dopaminergic neurons in Parkinson's disease
- (2011) D.J. Surmeier et al. NEUROSCIENCE
- In vivo demonstration that -synuclein oligomers are toxic
- (2011) B. Winner et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1
- (2010) Jaime N. Guzman et al. NATURE
- Compounds from an unbiased chemical screen reverse both ER-to-Golgi trafficking defects and mitochondrial dysfunction in Parkinson's disease models
- (2009) L. J. Su et al. Disease Models & Mechanisms
- Rapid selection of cyclic peptides that reduce α-synuclein toxicity in yeast and animal models
- (2009) Joshua A Kritzer et al. Nature Chemical Biology
- Bridging high-throughput genetic and transcriptional data reveals cellular responses to alpha-synuclein toxicity
- (2009) Esti Yeger-Lotem et al. NATURE GENETICS
- A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease
- (2009) C. Warren Olanow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hypothesis-based RNAi screening identifies neuroprotective genes in a Parkinson's disease model
- (2008) S. Hamamichi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started